Purdue Foundry

FOUNDERS

Steve Mogensen

CEO

Steve Mogensen is a seasoned medical device professional with over 25 years of experience in the medical device industry. Currently Mr. Mogensen serves as the President & CEO of SpeechVive, Inc. Previously Mr. Mogensen served as Managing Director of the Alfred Mann Institute at Purdue University, Vice President of Sales and Marketing at Enpath Medical which sold to Greatbatch Inc. in June, 2007, President and Co-Founder of Advanced Clinical Services, Inc., Vice President NPI at MedSource Technologies which went public in February 2002, and over 11 years at Smiths Medical in 7 roles.

Jessica Huber

Director & Chief Technology Officer

Jessica Huber received her Ph.D. in Speech Science from the University at Buffalo - State University of New York in June 2001. She joined the Department of Speech, Language, and Hearing Sciences at Purdue University in Fall 2001. Professor Huber’s primary area of research is speech motor control in both normal individuals and individuals with motor speech disorders, in particular Parkinson’s disease. Current research projects include studies of the effects of speech treatments, dopaminergic drugs, and deep-brain stimulation on speech in Parkinson’s disease. Doctor Huber currently serves as a Director and as Chief Technology Officer for SpeechVive, Inc.

PROFILE

SpeechVive, giving people with Parkinson’s a voice! Parkinson’s disease is one of the most common neurological degenerative diseases, the inability to speak loudly enough to be heard (hypokinetic dysarthria) is very common. 89% of people who have Parkinson’s disease will have issues with their speech. It is estimated that 1.5 million people in the U.S. and 8 million people worldwide suffer from Parkinson’s disease. SpeechVive is a behind the ear smart device which helps people with Parkinson’s disease speak more loudly and communicate more effectively based on the research of Dr. Jessica Huber at Purdue University. Clinical data over 4 years demonstrated SpeechVive to be effective in improving volume, articulation, and speech rate in 90% of the people participating in two multi-site clinical trials. Visit speechvive.com to see if SpeechVive can help you or a loved one regain their speech.

FUNDING PHASE

Series B

RAISED TO-DATE

$6.3 M

NOW HIRING

Clinical Marketing Manager

A speech language pathologist with at least 5 years of clinical experience who is interested in teaching other speech language pathologists how to program and use the SpeechVive device. The ideal candidate will be capable of traveling and speaking at Parkinson's support groups, collaborating with Movement Disorder Specialists, training speech language pathologists, while being dedicated to helping people who suffer from Parkinson's disease and their caregivers.